Å׵θ®
fDRzgSYmFkuXRu 217
I'd like to open an account https://www.autoshowsonline.com/stmap_18lfj5c.html drug-from-canada.com  In any case, the analyst said he expects Copaxone sales tofall to about $3.8 billion this year because of competition fromnew oral treatments for multiple sclerosis, including BiogenIdec's Tecfidera and Sanofi SA's Aubagio, andto fall to $3.4 billion in 2014 for the same reason, even if nogenerics are introduced.
Denver 2020-04-27 11:27:26

ȸ»ç¼Ò°³ | ã¾Æ¿À½Ã´Â ±æ | ÀÎÁõ³»¿ëº¸±â